Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Karyopharm (KPTI) assumed with an Outperform at Leerink. 2. BioXcel Therapeutics (BTAI) was initiated with a Buy at Canaccord and UBS, an Outperform at BMO Capital, and an Overweight at Barclays. 3. New York & Co. (NWY) initiated with a Buy at Roth Capital. 4. Sellas Life Sciences (SLS) initiated with a Buy at H.C. Wainwright. 5. Hanesbrands (HBI) initiated with a Neutral at Macquarie. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.